Seminars

A monthly seminar series is run at the Oglesby Cancer Research Building and at The University of Manchester. The series includes an outstanding range of invited speakers covering a wide field of research. The seminar series is important to encourage UK and international collaborations and connects researchers with the wider scientific community providing opportunity for interaction for both the speaker and the Centre.

Manchester Breast Centre Seminar Series 2024, funded by Breast Cancer Now

• Jason Carroll (Cambridge) – “ “The role of hormones and nuclear receptors in breast cancer”, 15th February, 2024
• Christine Desmedt (Leuven, Belgium) - “Tissue Donation Programs to Accelerate Metastasis Research”, 15th April 2024

Manchester Breast Centre Seminar Series 2023, funded by Breast Cancer Now

• Takanori Kitamura (Edinburgh) – “Targeting macrophages to improve NK infusion therapy for metastatic breast cancer”, 28th February, 2023
• Luca Magnani (Imperial College London) - "Sleepwalking through evolution: a tale of dormancy and hormone dependent breast cancer", 21st March, 2023
• Festschrift Meeting: a celebration of Professor Tony Howell's academinc achievements on 30th June, 2023 with invited speakers:
  • Bill Miller (Edinburgh)
  • Mitch Dowsett (ICR, London)
  • Kent Osborne (Baylor College of Medicine, USA) (video)
  • Cathrin Brisken (EPFL, Switzerland and ICR, London)
  • Rob Mansell (Cardiff)
  • Per Hall (Karolinska Institutet, Stockholm) (video)
  • Jack Cuzick (Queen Mary University of London)
  • Steve Hursting (North Carolina, USA) (video)
  • David Dodwell (Oxford)
  • John Robertson (Nottingham)
  • Mark Clemons (Ottawa, Canada) (video)
  • Per Lonning (Bergen, Norway)
  • Rob Coleman (Sheffield)
  • Lester Barr (Prevent Breast Cancer)
• Lynda Wyld (University of Sheffield) - "Care inequalities in older patients with breast cancer", 15th September, 2023
• Val Brunton (University of Edinburgh) - “Tumour-stromal interactions and adhesion proteins in breast cancer”, 2nd November, 2023
• Sara Pensa (University of Cambridge) - “Tumour Initiation Through Aberrant Differentiation: Lessons from Single Cell Genomics”, 1st December, 2023

Manchester Breast Centre Seminar Series 2022, funded by Breast Cancer Now

• Thomas Hughes (Leeds) – “Molecular mechanisms of chemoresistance in breast cancer”, 8th February, 2022
• Toral Gathani (Oxford) – “Ethnicity and Breast Cancer in the UK”, 1st March, 2022
• Andrew Holding & Katherine Bridge (York) - "Next generation strategies for characterising aberrant transcription factor function in cancer", 22nd March, 2022
• Manuel Valiente (CNIO, Spain) - “Strategies to challenge brain metastasis lethality in mice and human”, 24th May, 2022
• Jo Morris (Birmingham) - "BRCA1 stories of lethality and replication", 5th July, 2022
• Karen Blyth (Glasgow) - "The RUNX genes as enigmatic players in breast cancer", 6th September, 2022
• Elisabetta Marangoni (Paris) - “Oxidative phosphorylation is a metabolic vulnerability of metastatic breast cancers resistant to endocrine therapies and palbociclib”, 11th October, 2022

Manchester Breast Centre Seminar Series 2021, funded by Breast Cancer Now

• Roger Gomis (Barcelona) – “Mechanisms of breast cancer tissue-specific and time-dependent metastasis”, 19th January, 2021
• Steffi Osterreich & Adrian Lee (Pittsburgh) – “Understanding resistance to endocrine therapy in breast cancer”, 23rd February, 2021
• Jean Zhao (Harvard) – “Integrating immunotherapy and targeted therapy in cancer treatment: Mechanistic insights and clinical implications”, 30th March, 2021
• Shelley Potter (Bristol) - "Generating evidence to improve the outcomes of oncoplastic and reconstruction breast surgery - one step at a time", 11th May, 2021
• Kara Britt (Melbourne) - "Understanding breast cancer risk to find new ways to deliver breast cancer prevention", 15th June, 2021
• Bruce Mann & Belinda Parker (Melbourne) - "Toward precision therapy in DCIS", 20th July 2021
• Sharon Nofech-Mozes (Toronto) - "Individual Risk Assesssment for patients with DCIS, lessons learned from the Ontario DCIS Cohort", 28th September, 2021

• Joseph Jerry (Massachusetts) - “Genetic modifiers determining susceptibility to mammary tumors in p53 deficient mice and pathogenic actions of estrogen exposure”, 2nd November, 2021

• Mary Helen Barcellos-Hoff (San Francisco) - “Of Mice and Women:  New insights for the origin of tumor immune microenvironment of breast cancer”, 16th November, 2021

Breast Cancer Now-funded Manchester Breast Centre Seminar Series 2008-2020

108 Breast Cancer Now Seminars have taken place since the Breast Cancer Now Research Unit opened in 2008 and 2020.